These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Denys D Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723 [TBL] [Abstract][Full Text] [Related]
31. Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder. Asbahr FR; Castillo AR; Ito LM; Latorre MR; Moreira MN; Lotufo-Neto F J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1128-36. PubMed ID: 16239861 [TBL] [Abstract][Full Text] [Related]
33. Predictors of treatment response in pediatric obsessive-compulsive disorder. Ginsburg GS; Kingery JN; Drake KL; Grados MA J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):868-78. PubMed ID: 18596553 [TBL] [Abstract][Full Text] [Related]
34. Obsessive-compulsive disorder. Diagnosis and management. Ladouceur R; Freeston M; Gagnon F Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492 [TBL] [Abstract][Full Text] [Related]
35. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. Pediatric OCD Treatment Study (POTS) Team JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582 [TBL] [Abstract][Full Text] [Related]
36. Benefits of CBT for OCD in pregnancy. Dane BF; Storch EA Can Fam Physician; 2014 May; 60(5):430-2. PubMed ID: 24829001 [No Abstract] [Full Text] [Related]
37. Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis. Sánchez-Meca J; Rosa-Alcázar AI; Iniesta-Sepúlveda M; Rosa-Alcázar A J Anxiety Disord; 2014 Jan; 28(1):31-44. PubMed ID: 24334214 [TBL] [Abstract][Full Text] [Related]
38. [To identify and treat obsessive-compulsive disorders: an overview]. Voderholzer U; Hauer M; Stattrop U MMW Fortschr Med; 2013 Sep; 155(15):37-9. PubMed ID: 24224373 [No Abstract] [Full Text] [Related]
39. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. Franklin ME; Sapyta J; Freeman JB; Khanna M; Compton S; Almirall D; Moore P; Choate-Summers M; Garcia A; Edson AL; Foa EB; March JS JAMA; 2011 Sep; 306(11):1224-32. PubMed ID: 21934055 [TBL] [Abstract][Full Text] [Related]
40. Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial. Franklin ME; Kozak MJ; Cashman LA; Coles ME; Rheingold AA; Foa EB J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):412-9. PubMed ID: 9549962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]